On the behaviour of cerium(III) in hydrochloric acid

Summary The sorption of Ce³⁺ from hydrochloric acid and its chromatography on a column filled with Dowex 50 X8 was studied. The break-through volumes and elution volumes, together with the sorption profile and band broadening were determined at different temperatures and are discussed. The Chromatographic results are interpreted in terms of cerium complex formation.

---

Über das Verhalten von Cerium(III) in salzsaurer Lösung

Zusammenfassung Die Sorption von Ce³⁺ aus salzsaurer Lösung in einer mit Dowex 50 X8 gefüllten Säule sowie dessen Chromatographie wurden untersucht. Die Durchbruchs- und Elutionsvolumina wurden bestimmt und diskutiert. Die Ergebnisse wurden im Sinne einer Komplexbildung interpretiert.

     

马心血红蛋白在氧化铟电极上的直接电子传递反应

马心血红蛋白在氧化铟电极上的直接电子传递反应杨秀娟，菊，陆天虹（中国科学院长春应用化学研究所电分析化学开放实验室，长春，１３００２２）关键词血红蛋白，氧化铟电极，循环伏安法蛋白质与电极之间的电子转移在某种程度上类似于生物体内蛋白质分子之间的电子转移过...     

Application of dodecyldimethyl (2-hydroxy-3-sulfopropyl) ammonium in wall modification for capillary electrophoresis separation of proteins

A zwitterionic surfactant, dodecyldimethyl (2-hydroxy-3-sulfopropyl) ammonium (C12H25N+(CH3)2CH2CHOHCH2SO3-), named dodecyl sulfobetaine (DSB), was used as a novel modifier to coat dynamically capillary walls for capillary electrophoresis separation of basic proteins. The DSB coating suppressed the electroosmotic flow (EOF) in the pH range of 3-12. At high DSB concentration, the EOF was suppressed by more than 8.8 times. The DSB coating also prevented successfully the adsorption of cationic proteins on the capillary wall. Anions, such as Cl-, Br-, I-, SO4(2-), CO3(2-), and ClO4-, could be used as running buffer modifiers to adjust the EOF for better separation of analytes. Using this dynamically coated capillary, a mixture of eight inorganic anions achieved complete separation within 4.2 min with the efficiencies from 24,000 to 1,310,000 plates/m. In the presence of ClO4- as EOF adjustor, the separation of a mixture containing four basic proteins (lysozyme, cytochrome c, alpha-chymotrypsinogen A, and myoglobin) yielded efficiencies of 204,000-896,000 plates/m and recoveries of 88%-98%. Migration time reproducibility of these proteins was less than 0.5% relative standard deviation (RSD) from run to run and less than 3.1% RSD from day to day, showing promising application of this novel modifier in protein separation.     

The Structure of Bis[N‐6‐aminopyridyl‐N‐(1S)‐(+)‐10‐camphorsulfonylamino]palladium in the Solid State and in Solution

The complex, bis[N‐6‐aminopyridyl‐N‐(1S)‐(+)‐10‐camphorsulfonylamino]palladium, Pd[(S)‐APCS]₂, 1 , was prepared by reaction of 2‐[(1S)‐(+)‐10‐camphorsulfonamino]‐6‐aminopyridine with PdCl₂ in THF. Complex 1 has been characterized by spectroscopic methods and its structure has been determined by X‐ray crystallography. Crystal data: space group C2, a= 16.082 (2), b = 17.104 (2), c = 13.051 (2)Å, β = 99.95 (1)°, V = 3535.9 (8) ų, Z = 2 with final residuals R1 = 0.0491 and wR2 = 0.0944. Two independent molecules, (S,S)‐Pd[(S)‐APCS]2, 1a , and (R,R)‐Pd[(S)‐APCS]2, 1b , were found in each asymmetric unit, which exchange to each other via a series of nitrogen inversion and C‐C bond rotation. The inversion energy (ΔGc₁^≠) and the energy barrier (δGc₂^≠) were 11.5 ± 0.1 Kcal mol^?1 at 246 K and 9.8 ± 0.1 Kcal mol^?1 at 199 K, respectively, calculated by dynamic NMR data.     

Molecular spectroscopy of symmetric fragmentary exchange in N-oxypyridinium salts

A number of N-acetyloxypyridinium salts has been studied, using molecular spectroscopy methods. These compounds exist in solutions of bipolar solvents as ions and ion pairs of various structure. The association to ion pairs effects the frequences and intensities of characteristic vibrations, the chemical shifts of proton peaks, and the reaction rate of symmetric exchange of acetyl groups. Based on the spectrochemical correlations, data on the structure of the salts, the acetyl exchange reaction mechanism, and the influence of the solvent nature, the reagent structures, the additions of the base electrolyte and crown-ether on its kinetic characteristics have been obtained.     

A New Activation Method for Electroless Metal Plating：Palladium Laden via Bonding with Self—Assembly Monolayers

A new activation method has been developed for electroless copper plating on silicon wafer based on palladium chemisorption on SAMs of APTS without SnCl2 sensitization and roughening condition.A closely packed electroless copper film with strong adhesion is successfully formed by AFM observation.XPS study indicates that palladium chemisorption occurred via palladium chloride bonding to the pendant amino group of the SAMs.     

全自动固相萃取技术同时测定动物产品中9种磺胺药物残留

针对目前动物产品中兽药残留检测样品前处理繁琐的问题,应用全自动固相萃取技术对动物产品中9种磺胺类药物残留检测的样品前处理方法进行了系统的研究,对提取溶剂、固相萃取柱、淋洗液、洗脱溶剂及仪器分析条件进行了优化选择,建立了新型磺胺药物残留检测的全自动固相萃取净化方法.经不同检测单位验证,该方法的加标回收率为78.4%～107.8%,精密度为3.9%～11.0%检出限为0.010～0.020mg/kg,满足出口检测要求.     

An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies

The pH-selective interaction between the immunoglobulin G (IgG) fragment crystallizable region (Fc region) and the neonatal Fc receptor (FcRn) is critical for prolonging the circulating half-lives of IgG molecules through intracellular trafficking and recycling. By using directed evolution, we successfully identified Fc mutations that improve the pH-dependent binding of human FcRn and prolong the serum persistence of a model IgG antibody and an Fc-fusion protein. Strikingly, trastuzumab-PFc29 and aflibercept-PFc29, a model therapeutic IgG antibody and an Fc-fusion protein, respectively, when combined with our engineered Fc (Q311R/M428L), both exhibited significantly higher serum half-lives in human FcRn transgenic mice than their counterparts with wild-type Fc. Moreover, in a cynomolgus monkey model, trastuzumab-PFc29 displayed a superior pharmacokinetic profile to that of both trastuzumab-YTE and trastuzumab-LS, which contain the well-validated serum half-life extension Fcs YTE (M252Y/S254T/T256E) and LS (M428L/N434S), respectively. Furthermore, the introduction of two identified mutations of PFc29 (Q311R/M428L) into the model antibodies enhanced both complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity activity, which are triggered by the association between IgG Fc and Fc binding ligands and are critical for clearing cancer cells. In addition, the effector functions could be turned off by combining the two mutations of PFc29 with effector function-silencing mutations, but the antibodies maintained their excellent pH-dependent human FcRn binding profile. We expect our Fc variants to be an excellent tool for enhancing the pharmacokinetic profiles and potencies of various therapeutic antibodies and Fc-fusion proteins.Subject terms: Antibody therapy, Molecularly targeted therapy, Drug development